XELOX vs. FOLFOX in metastatic colorectal cancer: An updated meta-analysis

被引：74

作者：

Guo, Yu ^{[1
]}

Xiong, Bing-Hong ^{[2
]}

Zhang, Tao ^{[3
]}

Cheng, Yong ^{[1
]}

Ma, Li ^{[4
]}

机构：

[1] Chongqing Med Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, 1 Youyi Rd, Chongqing 400016, Peoples R China

[2] Kunming Med Univ, Affiliated Hosp 1, Dept Gastrointestinal & Hernia Surg, Sch Clin Med 1, Kunming, Peoples R China

[3] Chongqing Med Univ, Affiliated Hosp 1, Dept Oncol, Chongqing 400016, Peoples R China

[4] Third Hosp Mianyang, Dept Emergency, Mianyang, Peoples R China

来源：

CANCER INVESTIGATION | 2016年 / 34卷 / 02期

关键词：

Colorectal cancer; Fluorouracil; Capecitabine; Oxaliplatin; CAPECITABINE PLUS OXALIPLATIN; RANDOMIZED PHASE-III; 1ST-LINE TREATMENT; ORAL CAPECITABINE; COLON-CANCER; FLUOROURACIL; LEUCOVORIN; THERAPY; 5-FLUOROURACIL/LEUCOVORIN; SURVIVAL;

D O I：

10.3109/07357907.2015.1104689

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

This meta-analysis aims to evaluate chemotherapy with XELOX (capecitabine plus oxaliplatin) versus FOLFOX (fluorouracil plus oxaliplatin) as a treatment for metastatic colorectal cancer (mCRC) in terms of efficacy and safety. Only randomized controlled trials (RCTs) comparing XELOX versus FOLFOX were included. A total of 4,363 patients from eight RCTs were available for analysis. Pooled analysis revealed that there were no statistical differences between both arms in OS, and ORR. XELOX arm had a higher incidence of thrombocytopenia, hand-foot syndrome, and diarrhea, whereas neutropenia had a higher incidence in the FOLFOX group. For mCRC, the effect of XELOX is similar to FOLFOX.

引用

页码：94 / 104

页数：11

共 32 条

[31] Capecitabine plus oxaliplatin compared with 5-fluorouracil plus oxaliplatin in metastatic colorectal cancer: Meta-analysis of randomized controlled trials [J].

Zhang, Chengyao ;

Wang, Jiawu ;

Gu, Haitao ;

Zhu, Daihua ;

Li, Yang ;

Zhu, Peng ;

Wang, Yaxu ;

Wang, Jijian .

ONCOLOGY LETTERS, 2012, 3 (04) :831-838

[32] Capecitabine/oxaliplatin as first-line treatment for metastatic colorectal cancer: a meta-analysis [J].

Zhao, G. ;

Gao, P. ;

Yang, K. H. ;

Tian, J. H. ;

Ma, B. .

COLORECTAL DISEASE, 2010, 12 (07) :615-623

← 1 2 3 4 →